InspireMD
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, InspireMD sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
InspireMD: 3 sponsored US clinical trials, 1 recruiting.
InspireMD sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Carotid Artery Stenosis, with 1 trials.
Upper-quartile sponsor footprint
InspireMD sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
NCT06653387
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
NCT04900844
MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction
NCT01869738
Therapeutic Areas
What is open in the InspireMD pipeline
1 recruiting of 3 indexed (33% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Carotid Artery Stenosis (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
InspireMD: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
InspireMD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this InspireMD page
3 registered trials is a research-attention snapshot, not an endorsement of InspireMD or any single study.
- 1 of InspireMD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Carotid Artery Stenosis is the condition InspireMD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Carotid Artery Stenosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
InspireMD pipeline card: 3 registered trials from official public datasets.Report a data error.